Immunological changes during treatment interruptions: risk factors and clinical sequelae.
Poulton
Mary B
MB
Brighton Health Care NHS Trust, Royal Sussex County Hospital, Brighton, East Sussex BN2 5BE, UK.
Sabin
Caroline A
CA
Fisher
Martin
M
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D018450:Disease Progression; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D019562:Viral Load
D019380:Anti-HIV Agents